Evaluation of Benzenesulfonamide Derivatives; Quinazoline and Sulfonamide Selectively Targeting Carbonic Anhydrase XII for Tumor Microenvironment Modulation in Human Breast Cancer Cells
DOI:
https://doi.org/10.32947/ajps.v25i5.1306Keywords:
Benzenesulfonamide derivatives, Carbonic anhydrase, pH, Sulfonamide, QuinazolineAbstract
Tumor cells evolve adaptive mechanisms to function optimally within an acidic microenvironment. This adaptation is driven by the enhanced metabolic activity of tumors, which frequently results in acidosis and hypoxia. Carbonic anhydrase enzymes orchestrate cell homeostasis and affect cancer cell fate. Advances in structure-based design have enabled the identification of selective carbonic anhydrase XII inhibitors.
The study aimed to evaluate the anti-proliferative activity of sulfonamide derivatives and elucidate the plausible mode of action. MTT assay was conducted to evaluate cytotoxicity of acetazolamide, parent C3 and its derivatives C4 and C6 against breast cancer cell lines MCF-7, MDA-MB-231 and prostate cancer cells PC3. Further studies for C3, C4 and C6 compounds were conducted against MCF-7. Enzyme-linked immunosorbent assay of carbonic anhydrases IX and XII and fluorescent intracellular pH assay were conducted. Investigated compounds and acetazolamide reduced proliferation of all tested cells after 72 h. C3, C4, and C6 compounds reduced carbonic anhydrase XII concentrations. C3 and C6 did not appear significant reduction in CAIX in MCF-7. Conversely, C4 displayed statistically significant increase. Cells exposed to C3, C4, and C6 revealed a decrease in intracellular pH levels. In conclusion, all three compounds exhibited antiproliferative activities characterized by modulation of tumor pHi/pHe.
References
1- Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K. EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer. 2018 Feb;17(1):53. DOI: 10.1186/s12943-018-0793-1
2- Esfandiari Mazandaran K, Baharloui M, Houshdar Tehrani MH, Mirshokraee SA, Balalaie S. The synthesis of conjugated peptides containing triazole and quinolone-3-carboxamide moieties designed as anticancer agents. Iran J Biotechnol. 2021 Oct;19(4):e2917. DOI: 10.30498/ijb.2021.257765.2917
3- Abbas HAS, Nossier ES, El-Manawaty MA, El-Bayaa MN. New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity. Sci Rep. 2024 Jun;14(1):13028. DOI: 10.1038/s41598-024-62864-9
4- Roma-Rodrigues C, Mendes R, Baptista P V, Fernandes AR. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019;20(4):840. DOI: 10.3390/ijms20040840
5- Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004 Nov;4(11):891–9. DOI: 10.1038/nrc1478
6- Schwartz L, Supuran CT, Alfarouk KO. The Warburg Effect and the Hallmarks of Cancer. Anticancer Agents Med Chem. 2017;17(2):164–70. DOI: 10.2174/1871520616666161031143301
7- Al-Asady SH, Al-Sudani BT, Mshimesh BAR. Knockdown of α-enolase (ENO1) to suppress glycolytic pathway in human hepatocellular carcinoma cell line (HepG2). Iraqi J Pharm Sci. 2024 Jul;33(2):156–60. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2429.
8- Liao R, Ma QZ, Zhou CY, Li JJ, Weng NN, Yang Y, et al. Identification of biomarkers related to tumor-infiltrating lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer. Bioengineered. 2021 Dec;12(1):1676–88. DOI: 10.1080/21655979.2021.1921551
9- Kaluz S, Kaluzová M, Liao SY, Lerman M, Stanbridge EJ. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochim Biophys Acta. 2009 Apr;1795(2):162–72. DOI: 10.1016/j.bbcan.2009.01.001
10- Stadie WC, O’Brien H. The catalysis of the hydration of carbon dioxide and dehydration of carbonic acid by an enzyme isolated from red blood cells. J Biol Chem. 1933;103(2):521–9. Available from: https://www.sciencedirect.com/science/article/pii/S0021925818758316
11- Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem. 2021;13(21):1935–7. DOI: 10.4155/fmc-2021-0222
12- Wang J, Shi W, Miao Y, Gan J, Guan Q, Ran J. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Bioengineered. 2021 Dec;12(1):6286–304. DOI: 10.1080/21655979.2021.1971029
13- Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008 Feb;7(2):168–81. DOI: 10.1038/nrd2467
14- Singh S, Lomelino C, Mboge M, Frost S, McKenna R. Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules. 2018 Apr;23(5):1045. DOI: 10.3390/molecules23051045
15- Haapasalo J, Nordfors K, Haapasalo H, Parkkila S. The expression of carbonic anhydrases II, IX and XII in brain tumors. Cancers (Basel). 2020 Jun;12(7):1863. DOI: 10.3390/cancers12071723
16- Barnett DH, Sheng S, Charn TH, Waheed A, Sly WS, Lin CY, et al. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res. 2008 May;68(9):3505–15. DOI: 10.1158/0008-5472.CAN-07-6151
17- Kopecka J, Rankin GM, Salaroglio IC, Poulsen SA, Riganti C. P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors. Oncotarget. 2016 Dec;7(52):85861–75. DOI: 10.18632/oncotarget.13040
18- von Neubeck B, Gondi G, Riganti C, Pan C, Parra Damas A, Scherb H, et al. An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo. Int J Cancer. 2018 Oct;143(8):2065–75. DOI: 10.1002/ijc.31607
19- Huang T, Tang L, Wang H, Lin L, Fu J. Carbonic anhydrase 12 gene silencing reverses the sensitivity of paclitaxel in drug-resistant breast cancer cells. Bioengineered. 2021 Dec;12(2):9806–18. DOI: 10.1080/21655979.2021.1995575
20- Chen X, Zhou Z, Zhang Z, Zhao C, Li J, Jiang J, et al. Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII. Front Pharmacol. 2022;13:969422. DOI: 10.3389/fphar.2022.969422
21- Khan I, Ibrar A, Abbas N, Saeed A. Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications. Eur J Med Chem [Internet]. 2014;76:193–244. Available from: http://europepmc.org/abstract/MED/24583357. DOI: 10.1016/j.ejmech.2014.02.005
22- Akduman B, Crawford ED. Terazosin, doxazosin, and prazosin: current clinical experience. Urology. 2001 Dec;58(6 Suppl 1):49–54. DOI: 10.1016/s0090-4295(01)01302-4
23- Johnston S, Pippen JJ, Pivot X, Lichinitser M, Sadeghi S, Dieras V, et al. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer. J Clin Oncol. 2009 Nov;27(33):5538–46. DOI: 10.1200/JCO.2009.23.3734
24- Abutayeh RF, Almaliti J, Taha MO. Design and synthesis of new sulfonamides-based flt3 inhibitors. Med Chem. 2020;16(3):403–12. DOI: 10.2174/1573406415666190401144053
25- Tonissen KF, Poulsen SA. Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer. Cancer Drug Resist
[Internet]. 2021;4(2):343–55.
Available from: http://dx.doi.org/10.20517/cdr.2020.110
26- Ghorab MM, Alsaid MS, Al-Dosari MS, El-Gazzar MG, Parvez MK. Design, synthesis and anticancer evaluation of novel quinazoline-sulfonamide hybrids. Molecules. 2016;21(3):340. DOI: 10.3390/molecules21020189
27- Jasim ST, Mahdi MF. Molecular modeling, synthesis, and preliminary pharmacological evaluation of new sulfonamide derivatives as selective carbonic anhydrase XII and IX inhibitors. Al Mustansiriyah J Pharm Sci [Internet]. 2024 Apr;24(2):137–49. Available from: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1055. DOI: 10.32947/ajps. v24i2.1055
28- Maciel LLF, Silva MB, Moreira RO, Cardoso AP, Fernandes C, Horn AJ, et al. In vitro and in vivo relevant antineoplastic activity of platinum(ii) complexes toward triple-negative mda-mb-231 breast cancer cell line. Pharmaceutics. 2022 Sep;14(10):2076. DOI: 10.3390/pharmaceutics14102013
29- Khosravi M, Khazaeil K, KhademiMoghadam F. Triggering of the immune response to MCF7 cell line using conjugated antibody with bacterial antigens: in-vitro and in-vivo study. PLoS One. 2022;17(10):e0275776. DOI: 10.1371/journal.pone.0275776
30- Bedewi BK, Jasim GA, Abbas IS, Al-Sudani BT. Cytotoxicity of cryptochlorogenic acid against breast cancer cell line (MCF7) isolated from Moringa oleifera leaves cultivated in Iraq. Al Mustansiriyah J Pharm Sci [Internet]. 2022 Jul;22(2):35–43. Available from: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/837. DOI: 10.32947/ajps. v22i2.837
31- Yu WX, Lu C, Wang B, Ren XY, Xu K. Effects of rapamycin on osteosarcoma cell proliferation and apoptosis by inducing autophagy. Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):915–21.
32- Ahmed TH, Raoof IB, Mshemish BA. Evaluation of nicorandil in treatment of induced pulmonary arterial hypertension in male rats. Al Mustansiriyah J Pharm Sci [Internet]. 2024 Jul;24(3):330–42. Available from: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/1077. DOI: 10.32947/ajps. v24i3.1077
33- Jia Y, Chen L, Chi D, Cong D, Zhou P, Jin J, et al. Photodynamic therapy combined with temozolomide inhibits C6 glioma migration and invasion and promotes mitochondrial-associated apoptosis by inhibiting sodium-hydrogen exchanger isoform 1. Photodiagnosis Photodyn Ther. 2019 Jun;26:405–12. DOI: 10.1016/j.pdpdt.2019.05.007
34- Gut MO, Parkkila S, Vernerová Z, Rohde E, Závada J, Höcker M, et al. Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology. 2002 Dec;123(6):1889–903. DOI: 10.1053/gast.2002.37052
35- Leppilampi M, Karttunen TJ, Kivelä J, Gut MO, Pastoreková S, Pastorek J, et al. Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C. Transgenic Res. 2005 Oct;14(5):655–63. DOI: 10.1007/s11248-005-7215-z
36- Chiche J, Ilc K, Brahimi-Horn MC, Pouysségur J. Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration. Adv Enzyme Regul. 2010;50(1):20–33. DOI: 10.1016/j.advenzreg.2009.10.005
37- Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, Mazure NM, et al. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009 Jan;69(1):358–68. DOI: 10.1158/0008-5472.CAN-08-2470
38- Khajah MA, Almohri I, Mathew PM, Luqmani YA. Extracellular alkaline pH leads to increased metastatic potential of estrogen receptor silenced endocrine resistant breast cancer cells. PLoS One [Internet]. 2013 Oct;8(10):e76327. Available from: https://doi.org/10.1371/journal.pone.0076327. DOI: 10.1371/journal.pone.0076327
Downloads
Published
Issue
Section
License
Copyright (c) 2025 HIBA NABIL MIRAN, GHAITH ALI JASIM, TAREQ HAFDHI ABIDTAWFEEQ, AMMAR A. IBRAHIM AL-AZZAWI
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
